1. Home
  2. RXT vs DMRA Comparison

RXT vs DMRA Comparison

Compare RXT & DMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rackspace Technology Inc.

RXT

Rackspace Technology Inc.

HOLD

Current Price

$5.14

Market Cap

1.2B

Sector

Technology

ML Signal

HOLD

DMRA

Damora Therapeutics Inc. Common Stock

N/A

Current Price

$30.02

Market Cap

1.5B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
RXT
DMRA
Founded
1998
2011
Country
United States
United States
Employees
N/A
7
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.5B
IPO Year
2020
2020

Fundamental Metrics

Financial Performance
Metric
RXT
DMRA
Price
$5.14
$30.02
Analyst Decision
Hold
Buy
Analyst Count
6
2
Target Price
$1.71
$43.00
AVG Volume (30 Days)
14.1M
454.7K
Earning Date
05-07-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
75.13
N/A
EPS
0.03
N/A
Revenue
$2,685,700,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$1.35
N/A
P/E Ratio
$159.00
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.39
$16.50
52 Week High
$8.60
$34.89

Technical Indicators

Market Signals
Indicator
RXT
DMRA
Relative Strength Index (RSI) N/A 55.67
Support Level N/A $22.71
Resistance Level N/A $34.89
Average True Range (ATR) 0.00 2.10
MACD 0.00 -0.36
Stochastic Oscillator 0.00 28.19

Price Performance

Historical Comparison
RXT
DMRA

About RXT Rackspace Technology Inc.

Rackspace Technology Inc is an end-to-end, hybrid, multi-cloud technology services company. It designs, builds, and operates its customers' cloud environments across all technology platforms, irrespective of technology stack or deployment model. The company's solutions include Application Services, Data, Colocation, Cloud, Managed Hosting, Professional Services, and Security and Compliance. It has two reportable segments: Private Cloud and Public Cloud. Maximum revenue is generated from the Public Cloud segment, which offers cloud solutions through managed services, elastic engineering, and professional services offerings for customer environments hosted on the AWS, Microsoft Azure, and Google Cloud public cloud platforms. Geographically, the company derives its key revenue from the U.S.

About DMRA Damora Therapeutics Inc. Common Stock

Damora Therapeutics Inc is a biotechnology company that aims to fundamentally redefine care for people with hematologic disorders. The group is advancing a new generation of biologics to treat mutant calreticulin-driven myeloproliferative neoplasms, including essential thrombocythemia and myelofibrosis, where there is cruicial medical need for disease-modifying treatments. Its goal is to rapidly bring forward optimized therapies with broad mutation coverage and exceptional convenience to dramatically improve patient outcomes. The group's pipeline products are DMR-001, DMR-002, DMR-003, and GB3226.

Share on Social Networks: